Zoledronate and Molecular Iodine Cause Synergistic Cell Death in Triple Negative Breast Cancer through Endoplasmic Reticulum Stress.

@article{Tripathi2016ZoledronateAM,
  title={Zoledronate and Molecular Iodine Cause Synergistic Cell Death in Triple Negative Breast Cancer through Endoplasmic Reticulum Stress.},
  author={Ranu Tripathi and Preeti Singh and Aru Singh and Megha Chagtoo and Sajid Umar Khan and Swasti Tiwari and Gaurav Agarwal and Syed Musthapa Meeran and Madan Madhav Godbole},
  journal={Nutrition and cancer},
  year={2016},
  volume={68 4},
  pages={679-88}
}
Women consuming molecular iodine (I2) through seaweeds suffer the least from breast cancers. Zoledronate (Zol) is in clinical use for alleviation of bone pain in cancer patients. Triple negative breast cancers exhibit high mortality due to lack of neoadjuvant chemotherapy. I2 and Zol independently cause weak antiproliferative and apoptotic effect. So far… CONTINUE READING